Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Attovia Therapeutics
About ATTO
Attovia Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing biotherapeutics for immune-mediated diseases with high unmet need. Its lead pipeline candidates target commercially validated pathways and are designed through its ATTOBODY biologics platform to deliver improved treatments relative to the standards of care. Its ATTOBODY platform uses an evolution-driven, high-throughput process which allows for discovery and creation of a high diversity of potential product candidates. It is developing a pipeline of novel biotherapeutics for the treatment of immune-mediated diseases. Its first two product candidates for its immune-dermatology franchise, ATTO-1310 and ATTO-2306, have the potential to treat patients suffering from pruritic and lesional diseases. Its third program, ATTO-1091, broadens its reach to other inflammatory diseases, such as IBD, a therapeutic area with substantial unmet need. ATTO-1310 is an ATTOBODY-based therapeutic targeting interleukin-31.
Find out what a historical investment in Attovia Therapeutics would be worth today using our ATTO stock calculator.
Market Capitalisation
$802.49M
Price-earnings ratio
-
Dividend yield
0.00%
Volume
603.88K
High today
$19.30
Low today
$16.15
Open price
$18.68
52-week high
$22.79
52-week low
$18.50
Ready to start your investing journey with Stake?
Open an accountHow do I buy ATTO shares in Australia?
Buying ATTO shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Attovia Therapeutics in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in ATTO
What is the ticker symbol of Attovia Therapeutics?
The ticker symbol for Attovia Therapeutics is ATTO.
How much is one share of ATTO?
One share of ATTO is valued at $17.85 as of 13 August 2026.
What is the market capitalisation of Attovia Therapeutics ATTO?
As of 13 August 2026 Attovia Therapeutics has a market cap of $802.49M.
What is the 52-week high for Attovia Therapeutics stock?
The Attovia Therapeutics 52-week high stock price is $22.79.
What is the 52-week low for Attovia Therapeutics stock?
The Attovia Therapeutics 52-week low stock price is $18.50.
Can I buy ATTO shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy ATTO shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in ATTO on Stake
- Buy ATTO from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of ATTO from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
ATTO related stocks